Shortage topic
Oncology drug shortages
Oncology programs depend on predictable access to antineoplastics and supportive medicines. This hub links directory entries and insights for procurement teams - not treatment advice.
In short
Oncology drug shortages: B2B hub linking medications and insights. Availability depends on market conditions and regulations. Request availability through compliant inquiry workflows.
Medicines in this topic
- AbemaciclibOncologyNot listed
- AbirateroneOncologyNot listed
- Abiraterone AcetateOncologyNot listed
- AcalabrutinibOncologyNot listed
- AfatinibOncologyNot listed
- Alectinib HydrochlorideOncologyNot listed
- AlpelisibOncologyNot listed
- AnastrozoleOncologyNot listed
- AvapritinibOncologyNot listed
- Avutometinib Potassium Defactinib HydrochlorideOncologyNot listed
- AxitinibOncologyNot listed
- AzacitidineOncologyInjectionIn shortage
- BaricitinibOncologyNot listed
- BendamustineOncologyNot listed
- Bendamustine HclOncologyNot listed
- Bendamustine HydrochlorideOncologyNot listed
- BicalutamideOncologyNot listed
- Bictegravir Sodium Emtricitabine Tenofovir Alafenamide FumarateOncologyNot listed
- BinimetinibOncologyNot listed
- BleomycinOncologyNot listed
- Bleomycin SulfateOncologyNot listed
- BortezomibOncologyNot listed
- BosutinibOncologyNot listed
- BusulfanOncologyNot listed
- CabozantinibOncologyNot listed
- CapecitabineOncologyNot listed
- CapmatinibOncologyNot listed
- CarboplatinOncologyInfusionIn shortage
- CarmustineOncologyNot listed
- CeritinibOncologyNot listed
- ChlorambucilOncologyNot listed
- CisplatinOncologyInjectionNot listed
- ClofarabineOncologyNot listed
- CobimetinibOncologyNot listed
- CrizotinibOncologyNot listed
- CyclophosphamideOncologyNot listed
- CytarabineOncologyNot listed
- Cytarabine Liposome DaunorubicinOncologyNot listed
- DabrafenibOncologyNot listed
- DacarbazineOncologyNot listed
- DacomitinibOncologyTo be discontinued
- DactinomycinOncologyNot listed
- DasatinibOncologyNot listed
- Datopotamab DeruxtecanOncologyNot listed
- DaunorubicinOncologyNot listed
- Daunorubicin HydrochlorideOncologyNot listed
- DecitabineOncologyNot listed
- DeucravacitinibOncologyNot listed
Supply column: FDA drug shortage database - checked 16 Oct 2026